Skip to content

Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars

Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05102318
Enrollment
150
Registered
2021-11-01
Start date
2020-04-01
Completion date
2022-09-01
Last updated
2022-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulp Disease, Dental

Keywords

Direct pulp capping, Partial Pulpotomy, and Pulpotomy

Brief summary

The aim of the present study is to evaluate Mineral Trioxide Aggregate and Biodentine in direct pulp capping, partial pulpotomy, and pulpotomy in primary molars.

Detailed description

Screening of patients will continue until the target population is achieved. Identifying and recruiting potential subjects is achieved through patient database in Pediatric Dentistry department. A total of 150 primary molars from healthy subjects will be selected from the Pediatric Dentistry and Dental Public Health outpatient clinic, Faculty of Dentistry, Ain shams University. Subjects will be assigned randomly into two different treatment groups as follows: MTA Group (1): 1. Group 1(A): MTA Direct Pulp Capping. (n=25) 2. Group 1 (B): MTA Partial Pulpotomy. (n=25) 3. Group 1 (C): MTA Complete Pulpotomy. (n=25) BiodentineTM Group (2): 1. Group 2(A): BiodentineTM Direct Pulp Capping. (n=25) 2. Group 2 (B): BiodentineTM Partial Pulpotomy. (n=25) 3. Group 2 (C): BiodentineTM Complete Pulpotomy. (n=25)

Interventions

Direct Pulp Capping

Partial Pulpotomy

PROCEDUREPulpotomy

Pulpotomy

Sponsors

Ain Shams University
CollaboratorOTHER
British University In Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
4 Years to 7 Years
Healthy volunteers
Yes

Inclusion criteria

* No clinical symptoms or history implying irreversible pulpitis such as spontaneous pain, or pain persisting after stimuli removal. * Absence of periapical or interadicular radiolucencies, inflammatory root resorption, sinus tract or gingival abscess.

Exclusion criteria

* Children who are extremely uncooperative and difficult to manage. * Children suffering from any physically or mentally disability that will complicate the treatment: Special Health Care needs (SHCN). * Teeth of poor prognosis due to presence of an abscess or a sinus, mobility, advanced bone or root resorption or Non-Restorable teeth.

Design outcomes

Primary

MeasureTime frameDescription
Is to evaluate the clinical and radiographic success rates of Mineral Trioxide Aggregate and Biodentine in direct pulp capping, partial pulpotomy, and pulpotomy in primary molars.18 monthsIs to evaluate the clinical and radiographic success rates of Mineral Trioxide Aggregate and Biodentine in direct pulp capping, partial pulpotomy, and pulpotomy in primary molars.

Countries

Egypt

Contacts

Primary ContactMarwa Magdy, PhD
marwa.magdy@bue.edu.eg00201007195996
Backup ContactNadia Metwalli, Professor
nadia.metwalli@bue.edu.eg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026